Israeli strikes kill eight people in Gaza - medics say Reuters
Why TFX Stock advanced +1.73% Today — RQD Quant Desk Flash
Teleflex Incorporated (TFX) carries a Roarable Rating of D (Sell) with 48/100 RQD Confidence due to weak cash-flow efficiency and sensitivity to current interest rates. Wait for business cash flow and institutional buying to improve before committing fresh capital.
Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer
Why TFX Stock advanced +1.73% Today — RQD Quant Desk Flash
Teleflex Incorporated (TFX) advanced +1.73% to $141.39, trading at 92% of its 52-week range ($100.18 – $145). Stretched risk/reward at current multiples (2% return on capital) under elevated 10-year interest-rate pressure.
- ▸Technical Tape: Trading at 92% of its 52-week range ($100.18 – $145) with RSI-14 at 70.2 (OVERBOUGHT (>70)).
- ▸Volatility Profile: Historical 20-day realized swing band of ±5.7% around $141.39 (no active unusual options sweep snapshot on file).
- ▸Primary SEC / Cross-Feed Trigger: TFX Exhibits 1.31x True Net Liquidity Elasticity as Fed-TGA-RRP Prints $5,746B
Russia's FSB says minor detained over park attack threat after US tip-off Reuters
Iran, Qatari mediators hold third day of talks to end US-Iran war Reuters
Qatar surges, bucking Gulf market slide on Iran war concerns Reuters
OPEC+ keeps December oil output targets steady ahead of tougher call for 2027 Reuters
German ministers pledge tough action after rioters damage stores in Frankfurt Reuters
Pope Leo says he hopes Oleshky truce could spur Ukraine-Russia peace efforts Reuters
Xiaomi's October EV deliveries top 50,000, hit 2026 monthly high Reuters
Red-Light Warning Desk: Spotting SEC Cash-Flow & Dilution Risks Before Downgrades (Featuring TFX)
- ✓Walkthrough of TFX's RQD Radar, SEC cash-conversion gap & downside invalidation levels
- ✓3 asymmetric Bear/Hedge frameworks when 10-year Treasury yields stay elevated
- ✓Includes nightly RQD rating-change & forensic signal email alerts on your tracked stocks
TFX Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure
Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).
vs. +17.2% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).
No active Ellis Vennor swing setup published on TFX today. View full Setup Ledger →
No direct multi-tier Butterfly edges indexed yet for TFX. Explore sector supply chains on /butterfly.
📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (TFX)
1. Head-to-Head Health Care Peer Comparison (TFX vs. MMSI, HAE, MMED, HTFL)
Industry: Medical/Dental Instruments (21 Tracked Issuers)Across 188 tracked Health Care securities in the Roarable RQD universe, Teleflex Incorporated (TFX) ranks #156 by composite RQD confidence (48/100, grade D) and #146 by equity capitalization ($5.99B). Within this direct 5-issuer industry benchmark cohort, MMSI leads on earnings valuation at 43.4x trailing P/E, while HAE leads on capital efficiency and profitability with 8.4% ROIC and 59.0% gross margin. MMSI currently holds the highest overall quantitative score in the immediate peer group at 75/100 (B) compared with TFX at 48/100 (D).
| Ticker / Company | Roarable Grade | RQD Score | Trailing P/E | Gross Margin | ROIC | 1D Change | Market Cap | Head-to-Head |
|---|---|---|---|---|---|---|---|---|
| TFX
ACTIVE
Teleflex Incorporated | D | 48/100 | — | 56.2% | 1.8% | +1.73% | $5.99B | Benchmark Subject |
| MMSI Merit Medical Systems Inc. | B | 75/100 | 43.4x | 48.7% | 7.8% | +1.28% | $5.58B | /mmsi-vs-tfx → |
| HAE Haemonetics Corporation | B | 74/100 | — | 59.0% | 8.4% | +1.24% | $5.45B | /hae-vs-tfx → |
| MMED MiniMed Group Inc. | D | 46/100 | — | 54.2% | -3.9% | +0.21% | $5.42B | /mmed-vs-tfx → |
| HTFL Heartflow Inc. | D+ | 53/100 | — | 76.8% | -12.0% | +2.42% | $5.26B | /htfl-vs-tfx → |
2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)
SEC EDGAR 10-K • FILED 2025-12-31 • CIK 0000096943In its most recent audited fiscal period (FY2025, filed 2025-12-31), Teleflex Incorporated (TFX) reported GAAP revenue of $1.99B (+17.2% vs. FY2024 revenue of $1.70B , and +16.4% cumulative change since FY2023) , GAAP net income of -$905.6M, operating cash flow of $0, and free cash flow of $0 . On the balance sheet, TFX closed FY2025 with $6.95B in total assets against $2.54B in total debt (Altman Z-Score: 2.12, Piotroski F-Score: 4/9).
| Fiscal Period | Filing Date | Revenue | Net Income | Operating Cash Flow | Free Cash Flow | Total Assets | Total Debt |
|---|---|---|---|---|---|---|---|
| FY2025 (FY) | 2025-12-31 | $1.99B | -$905.6M | — | — | $6.95B | $2.54B |
| FY2024 (FY) | 2024-12-31 | $1.70B | $70.2M | — | — | $7.10B | $1.56B |
| FY2023 (FY) | 2023-12-31 | $1.71B | $357.6M | — | — | $3.30B | $771.0M |
3. TFX Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)
✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLEDIs TFX stock a Buy, Hold, or Sell right now according to Roarable's RQD model?
As of 2026-11-01, Teleflex Incorporated (NYSE: TFX) is rated D (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 48/100 at a spot price of $141.39 (+1.73% 1D, market cap $5.99B). Pillar breakdown: Fundamental Cash Engine 6/20, Institutional 13F & Options Flow 17/20, Executive Insider Alignment 9/20, FRED Macro Regime Fit 11/20, and SEC Balance-Sheet Forensics 5/20. Active quantitative signal LIQUIDITY_TAILWIND (BULLISH, conviction undefined/100) notes: undefined.
How does TFX compare to MMSI and HAE in the Health Care sector?
Within the Health Care sector (Medical/Dental Instruments), TFX carries a Roarable D (48/100 RQD), trailing P/E of N/A, gross margin of 56.2%, and ROIC of 1.8%. By comparison, MMSI (Merit Medical Systems Inc.) holds a B grade (75/100 RQD, P/E 43.4x, ROIC 7.8%, cap $5.58B) and HAE (Haemonetics Corporation) posts a B grade (74/100 RQD, P/E N/A, ROIC 8.4%, cap $5.45B). Among the 5-stock peer group, MMSI leads on earnings multiple (43.4x) while HAE leads on capital efficiency (8.4% ROIC).
What are the biggest fundamental strengths and SEC risk factors for TFX?
Per TFX's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0000096943), Teleflex Incorporated generated $1.99B in revenue (+17.2% YoY), -$905.6M in net income, and $0 in free cash flow against $6.95B in total assets and $2.54B in total debt. Key quantitative strengths: Big institutional funds and options desks are actively positioning on the bullish side.. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately.. Institutional options positioning shows a 50% call / 50% put premium split.
Where is TFX trading relative to its 50-day, 200-day, and 52-week technical levels?
TFX last traded at $141.39 (+1.73% on volume of 838,012 shares), positioning the stock +7.61% above its 50-day simple moving average ($131.39) and +12.81% above its 200-day simple moving average ($125.34). Across its 52-week range of $100.18 to $145.00, TFX sits at the 91.9% percentile with a 14-day RSI of 70.2 (OVERBOUGHT (>70)) and an implied next-earnings move of ±5.7% ($133.33 to $149.45).
TFX Investor FAQ & Complete 8-Part Research Index
100% OPEN ACCESS • SEC EDGAR × CBOE × FREDWhy is TFX stock moving today?
Why TFX Stock advanced +1.73% Today — RQD Quant Desk Flash. Stretched risk/reward at current multiples (2% return on capital) under elevated 10-year interest-rate pressure.